NCT Number: NCT00329264
Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder
The purpose of this study is to demonstrate that quetiapine SR (SEROQUEL®) is efficacious and safe in the acute treatment of patients with Generalized Anxiety Disorder.
PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.
Looking for future studies?
Notify MeKey information
Age range
18 year–65 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
Research Site, Springdale, Arizona, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patient has a documented clinical diagnosis of Generalized Anxiety Disorder.
- Be able to understand and comply with the requirements of the study.
- Able to understand and provide written informed consent
Exclusion criteria
- Patients (female) must not be pregnant or lactating
- Current or past diagnosis of stroke or transient ischemic attack (TIA).
Treatment and study plan
Primary outcomes
-
Change from randomization in the HAM-A total score at Day 57
Secondary outcomes
-
Change from randomization in CGI-S score at Day 57
Sponsors and collaborators
Lead sponsor
AstraZeneca
Industry
Registry information
Official study title
A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of the Efficacy and Safety of Sustained-Release Quetiapine Fumarate (SEROQUEL®) Compared With Placebo in the Treatment of Generalized Anxiety Disorder
Acronym: TITANIUM
Important dates
- Study start
- 2006
- Study completion
- 2007
- First posted
- May 24, 2006
- Registry last updated
- Mar 25, 2009
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Computerized Intervention Targeting the Error-Related Negativity and Balance N1 in Anxious Children
NCT05503017
Anxiety Disorders, Generalized Anxiety Disorder
Tallahassee, Florida, United States
View Trial DetailsBrain Response Associated With Parent-based Treatment for Childhood Anxiety Disorders
NCT03585010
Anxiety Disorder of Childhood, Anxiety Disorders
New Haven, Connecticut, United States
View Trial DetailsTranscranial Direct Current Stimulation (tDCS) in Different Psychiatric Disorders
NCT07452835
Anxiety Disorders, Depressive Disorder
Cairo, Menofia, Egypt
View Trial DetailsAdaptation and Feasibility of the Community-Based Anxiety Program Tailored for Autism (CAPTA)
NCT06046170
Anxiety, Anxiety Disorders
Baltimore, Maryland, United States
View Trial Details